Teriparatide, osteoporosis, calcium, and vitamin D

被引:0
作者
Krege, JH [1 ]
Donley, DW [1 ]
Marcus, R [1 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:634 / 635
页数:2
相关论文
共 3 条
  • [1] Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate
    Ettinger, B
    San Martin, J
    Crans, G
    Pavo, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (05) : 745 - 751
  • [2] HODSMAN AB, IN PRESS ENDOCR REV
  • [3] Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    Neer, RM
    Arnaud, CD
    Zanchetta, JR
    Prince, R
    Gaich, GA
    Reginster, JY
    Hodsman, AB
    Eriksen, EF
    Ish-Shalom, S
    Genant, HK
    Wang, OH
    Mitlak, BH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (19) : 1434 - 1441